Canada Recommends Public Coverage for Second Alzheimer’s Drug

Canada’s Drug Agency is recommending public coverage for donanemab, a disease-modifying treatment for early-stage Alzheimer’s disease, though the expert committee set strict pricing and clinical conditions before provincial drug plans should pay the estimated $47,250 annual cost. According to a draft report released by the Canadian Drug Expert Committee, the infusion therapy provides clinical benefits … Read more

Alberta NDP Flips Reliable UCP Riding Amid Separation Backlash

Alberta’s ruling United Conservative Party lost the south Calgary riding of Calgary-Shaw to Alberta NDP candidate Kyle Campbell by 582 votes in a Monday by-election, according to preliminary results from Elections Alberta. Campbell secured roughly 47 per cent of the vote in the contest, defeating UCP candidate Mike Derry just one month before the province’s … Read more

Severe Storms Flood Ontario and Cause Toronto Power Outages

Severe storms swept across the Greater Toronto Area on Wednesday, September 2, 2026, bringing torrential rain, large hail, and a risk of a tornado that resulted in widespread power outages, localized flooding, and significant damage to public and commercial infrastructure, according to Environment Canada and local reports. Infrastructure Damage and Power Outages Across Toronto The … Read more

Bank of Canada Expected to Hold Rates Amid Escalating Trade War

The Bank of Canada is expected to maintain its benchmark interest rate at 2.25 per cent as policymakers weigh escalating trade tensions with the United States against persistent inflation risks, according to financial analysts and economic polling. Following the breakdown of trade talks and subsequent tariff exchanges, markets widely anticipate a watchful-waiting stance rather than … Read more

Head of Federal Agency Organizing Carney’s Investment Summit Resigns

Laurel Broten, chief executive officer of Invest in Canada, is resigning from her position leading the federal agency tasked with organizing Prime Minister Mark Carney’s high-stakes Canada Investment Summit, according to a source familiar with the matter cited by The Globe and Mail. Broten, a former Ontario cabinet minister and Bay Street litigator who has … Read more

Canadian Matt Johnson Stars in Anthony Bourdain Biopic Tony

Director Matt Johnson and actor Dominic Sessa are teaming up for Tony, a new biographical drama focusing on the formative teenage years of late chef and author Anthony Bourdain, according to production details and interviews from the film’s Toronto premiere. Set during the summer of 1975 in Provincetown, Massachusetts, the A24 film departs from traditional … Read more

Canada’s Economy Grows 0.3% in May, Beating Expectations

The Canadian economy expanded by 0.3 per cent in May, beating economist forecasts and extending a spring rebound that puts second-quarter annualized growth on track to surpass 3 per cent, according to Statistics Canada data released on Friday. While resources and construction drove the broad-based gains, economists warn that impending U.S. tariffs and geopolitical energy … Read more

U.S. and Saudi Arabia Strike Iran Allies as Tehran Targets Jordan Bases

According to Reuters and Fox News, the United States and Saudi Arabia jointly struck Iran-backed groups in Iraq on Wednesday, driving Brent crude futures up more than 7 percent past US$90 a barrel. President Donald Trump vowed to hit Iran hard after Tehran confirmed it fired on U.S. bases in Jordan and ships in the … Read more

Carney’s Words Fall Short if Nutrien Bypasses BC for US Port

Nutrien, a dominant global potash miner based in Saskatchewan, has chosen to invest upwards of $1-billion in the Port of Longview, Washington, rather than expand through British Columbia’s Port of Vancouver. According to regulatory compliance consultant, banking historian, and Globe and Mail contributing columnist John Turley-Ewart, this cross-border capital flight serves as a stark red … Read more

Canada Recommends Public Coverage for Alzheimer’s Drug in Policy Reversal

Canada’s Drug Agency has reversed its initial stance, now recommending that public drug plans provide coverage for the Alzheimer’s medication lecanemab, provided specific clinical and safety conditions are met. The Canadian Drug Expert Committee (CDEC) updated its recommendation on Thursday, citing new evidence and a pressing clinical need, despite lingering concerns over the drug’s high … Read more